Quality of Pharma-sponsored Health Information on the Internet
What is the attitude of pharmaceutical professionals regarding the quality of pharma-sponsored health information on the Net? Does the industry perceive a problem in this area? To help answer this question, a survey - Quality of Pharma-Sponsored Health Information on the Internet - was sponsored by the Internet Healthcare Coalition in conjunction with the Pharma Marketing Network (PMN) and was hosted by PollingPharma on their web site (www.pollingpharma.com) during the month of January, 2003
Quality of Pharma-sponsored Health Information on the Internet
What is the attitude of pharmaceutical professionals regarding the quality of pharma-sponsored health information on the Net? Does the industry perceive a problem in this area? To help answer this question, a survey - Quality of Pharma-Sponsored Health Information on the Internet - was sponsored by the Internet Healthcare Coalition in conjunction with the Pharma Marketing Network (PMN) and was hosted by PollingPharma on their web site (www.pollingpharma.com) during the month of January, 2003
Pharma Marketing News Vol. 2, #2: February 2003
PHARMA MARKETING NEWS is the monthly newsletter of the PHARMA-MKTING interactive discussion group. It includes original articles, opinions from leaders in the field of interactive pharmaceutical marketing, industry news briefs, interviews with industry experts, and highlights of pharmaceutical e-marketing meetings.
Quality of Pharma-sponsored Health Information on the Internet
What is the attitude of pharmaceutical professionals regarding the quality of pharma-sponsored health information on the Net? Does the industry perceive a problem in this area? To help answer this question, a survey - Quality of Pharma-Sponsored Health Information on the Internet - was sponsored by the Internet Healthcare Coalition in conjunction with the Pharma Marketing Network (PMN) and was hosted by PollingPharma on their web site (www.pollingpharma.com) during the month of January, 2003
PhRMA Code Helps Re-define Roles of Medical Affairs and Marketing
A power shift from marketing to medical affairs may be the result of the new PhRMA Code on Interactions with Healthcare Professionals as well as the final Compliance Program Guidance for Pharmaceutical Manufacturers issued on April 28, 2003, by the HHS Office of Inspector General (OIG).
Impact of DTC Advertising of the Doctor-Patient Relationship
This article reviews a presentation by Kathryn Aikin of DDMAC/FDA in which she disclosed preliminary results from the FDA's Physician Survey, which looked at the impact of DTC advertising on the doctor-patient relationship
Online and Offline Professional and Consumer Marketing
Attending conferences like the recent Pharmaceutical Marketing Global Summit
provides tidbits of information about how pharma marketing practices need to evolve. Although the advice from one expert often conflicts with that of another, and sometimes the advice is self-serving, some suggestions seem to ring true and have universal support.
Has DTC Spending Peaked?
There are powerful lobbyists, including employers, insurers, AARP, and Public Citizen, with an anti-DTC agenda in Washington. The criticism takes many forms - increases in drug prices, increase in inappropriate prescribing, etc. Republicans have gained control, but some committee chairs are DTC critics.
Top Companies, Classes, and Products in the DTC Space
This article provides an overview of DTC spending YTD 2002 compared with YTD 2001. The sources the data are Verispan's Source Prescription Audit and other market research.
Top Companies, Classes, and Products in the DTC Space
This article provides an overview of DTC spending YTD 2002 compared with YTD 2001. The sources the data are Verispan's Source Prescription Audit and other market research.
